Linked Data API

Show Search Form

Search Results

1697270
registered interest false more like this
date less than 2024-03-19more like thismore than 2024-03-19
answering body
Department for Environment, Food and Rural Affairs more like this
answering dept id 13 more like this
answering dept short name Environment, Food and Rural Affairs more like this
answering dept sort name Environment, Food and Rural Affairs more like this
hansard heading Plants: Northern Ireland more like this
house id 2 remove filter
legislature
25277
pref label House of Lords more like this
question text To ask His Majesty's Government which plants, trees and seeds are not allowed to be sent to Northern Ireland from Great Britain as a result of the Windsor Framework. more like this
tabling member printed
Baroness Hoey more like this
uin HL3399 more like this
answer
answer
is ministerial correction false more like this
date of answer less than 2024-04-22more like thismore than 2024-04-22
answer text <p>The Windsor Framework provides for simplified arrangements for the movement of plants and plant products between Great Britain and Northern Ireland, meaning a phytosanitary certificate is not required and that a wider variety of plants can move.</p><p> </p><p>We have secured the lifting of a ban on the movement of twelve plant species - apple, Japanese / delavay privet, European crab apple, common hawthorn, Norway maple, Japanese maple, sycamore maple, field maple, English oak, sessile oak, European beech and, most recently, hazel. We are in active dialogue with the EU Commission on a number of other species which industry has proposed as priorities. We will continue to engage with industry to ensure the smooth movement of additional plant species. Further details can be found on Defra’s online Plant Health Portal.</p> more like this
answering member printed Lord Douglas-Miller more like this
question first answered
less than 2024-04-22T13:14:33.62Zmore like thismore than 2024-04-22T13:14:33.62Z
answering member
5006
label Biography information for Lord Douglas-Miller more like this
tabling member
210
label Biography information for Baroness Hoey more like this
1698225
registered interest false more like this
date less than 2024-03-22more like thismore than 2024-03-22
answering body
Foreign, Commonwealth and Development Office more like this
answering dept id 208 more like this
answering dept short name Foreign, Commonwealth and Development Office more like this
answering dept sort name Foreign, Commonwealth and Development Office more like this
hansard heading Bahrain: Visits Abroad more like this
house id 2 remove filter
legislature
25277
pref label House of Lords more like this
question text To ask His Majesty's Government whether Bahrain has paid for the flights or accommodation of any Minister visiting that country in the past four years; and if so, who the Ministers were, what were the reasons for their visits, and the cost of (1) the flights, and (2) the accommodation. more like this
tabling member printed
Lord Scriven more like this
uin HL3566 more like this
answer
answer
is ministerial correction false more like this
date of answer less than 2024-04-22more like thismore than 2024-04-22
answer text <p>We do not hold this information on behalf of HMG; it is held by each Government department for their own ministers. In the case of FCDO Ministers, we do not hold this information centrally and it could only be obtained at disproportionate cost.</p><p>The FCDO publishes details of FCDO Ministers' meetings with external organisations, gifts (given and received), hospitality and overseas travel every quarter. This information can be found at https://www.gov.uk/government/collections/fcdo-ministerial-gifts-hospitality-travel-and-meetings.</p> more like this
answering member printed Lord Ahmad of Wimbledon more like this
question first answered
less than 2024-04-22T13:01:23.99Zmore like thismore than 2024-04-22T13:01:23.99Z
answering member
4210
label Biography information for Lord Ahmad of Wimbledon more like this
tabling member
4333
label Biography information for Lord Scriven more like this
1698276
registered interest false more like this
date less than 2024-03-25more like thismore than 2024-03-25
answering body
Foreign, Commonwealth and Development Office more like this
answering dept id 208 more like this
answering dept short name Foreign, Commonwealth and Development Office more like this
answering dept sort name Foreign, Commonwealth and Development Office more like this
hansard heading Israel: Gender Based Violence and Sexual Offences more like this
house id 2 remove filter
legislature
25277
pref label House of Lords more like this
question text To ask His Majesty's Government what assessment they have made of reports by UN experts on 19 February of “credible allegations of egregious human rights violations” against Palestinian women and girls in Gaza and the West Bank by Israel Defence Forces; and whether they have offered practical support for investigating these alleged crimes, and for caring for survivors and witnesses. more like this
tabling member printed
Baroness Helic more like this
uin HL3580 more like this
answer
answer
is ministerial correction false more like this
date of answer less than 2024-04-22more like thismore than 2024-04-22
answer text <p>The UK condemns human rights abuses and sexual violence unequivocally and without exception. As I [Lord Ahmad] said to the UN Security Council during the 11 March debate following the release of Special Representative Pramila Patten's report, it is vital that all reports of sexual violence are fully investigated to ensure justice for all victims and survivors and perpetrators are held to account.</p><p>The FCDO continues to closely monitor the situation in Israel and the Occupied Palestinian Territories and stands ready to further utilise our Preventing Sexual Violence in Conflict Initiative (PSVI) expertise and tools to ensure victims and survivors of CRSV, both Israeli and Palestinian, receive the holistic and survivor-centred support they need.</p><p>Through our PSVI programmes and dedicated funding totalling £60 million since 2012, we are leading work internationally to prevent conflict-related sexual violence and strengthen justice and support for all survivors.</p> more like this
answering member printed Lord Ahmad of Wimbledon more like this
question first answered
less than 2024-04-22T13:03:32.307Zmore like thismore than 2024-04-22T13:03:32.307Z
answering member
4210
label Biography information for Lord Ahmad of Wimbledon more like this
tabling member
4331
label Biography information for Baroness Helic more like this
1699303
registered interest false more like this
date less than 2024-03-27more like thismore than 2024-03-27
answering body
Foreign, Commonwealth and Development Office more like this
answering dept id 208 more like this
answering dept short name Foreign, Commonwealth and Development Office more like this
answering dept sort name Foreign, Commonwealth and Development Office more like this
hansard heading UNRWA: Textbooks more like this
house id 2 remove filter
legislature
25277
pref label House of Lords more like this
question text To ask His Majesty's Government whether they have any evidence that UNRWA is inciting hatred of Jews in the textbooks it provides in its schools in Gaza. more like this
tabling member printed
Lord Turnberg more like this
uin HL3700 more like this
answer
answer
is ministerial correction false more like this
date of answer less than 2024-04-22more like thismore than 2024-04-22
answer text <p>We regularly discuss issues related to the school curriculum and textbooks with the Palestinian Authority (PA) and UNRWA. The UK-supported 2021 review of the PA curriculum found improvements in content, with previously flagged materials removed. But it also indicated that problematic content remains in Palestinian textbooks: we therefore need to see further curriculum reform from the PA, and we continue to raise this with them regularly. UNRWA and the PA are engaging seriously on this issue.</p><p>Antisemitism is abhorrent and has absolutely no place in any society, and we are committed to tackling it in all its forms.</p> more like this
answering member printed Lord Ahmad of Wimbledon more like this
question first answered
less than 2024-04-22T10:39:16.393Zmore like thismore than 2024-04-22T10:39:16.393Z
answering member
4210
label Biography information for Lord Ahmad of Wimbledon more like this
tabling member
2537
label Biography information for Lord Turnberg more like this
1700671
registered interest false more like this
date less than 2024-04-15more like thismore than 2024-04-15
answering body
Department of Health and Social Care more like this
answering dept id 17 more like this
answering dept short name Health and Social Care more like this
answering dept sort name Health and Social Care more like this
hansard heading Drugs: Shortages more like this
house id 2 remove filter
legislature
25277
pref label House of Lords more like this
question text To ask His Majesty's Government what steps they are taking to mitigate the current shortage of the psychotropic medication Olanzapine, Risperidone and Haloperidol following the sudden departure of two generic manufacturers from the UK market. more like this
tabling member printed
Lord Carlile of Berriew more like this
uin HL3729 more like this
answer
answer
is ministerial correction false more like this
date of answer less than 2024-04-22more like thismore than 2024-04-22
answer text <p>We are aware that there have been supply constraints with olanzapine 210 milligram, 300 milligram, and 405 milligram powder and solvent for prolonged release suspension for injection. We worked with manufacturers to uplift production, and the issues were resolved in February 2024. We worked with NHS England to issue national communications containing advice on how to manage patients whilst there was a disruption to supply. We are not aware of any supply issues affecting oral presentations of olanzapine, or of any supply issues with any risperidone or haloperidol products.</p> more like this
answering member printed Lord Markham more like this
grouped question UIN HL3730 more like this
question first answered
less than 2024-04-22T15:15:21.697Zmore like thismore than 2024-04-22T15:15:21.697Z
answering member
4948
label Biography information for Lord Markham more like this
tabling member
1138
label Biography information for Lord Carlile of Berriew more like this
1700672
registered interest false more like this
date less than 2024-04-15more like thismore than 2024-04-15
answering body
Department of Health and Social Care more like this
answering dept id 17 more like this
answering dept short name Health and Social Care more like this
answering dept sort name Health and Social Care more like this
hansard heading Olanzapine: Shortages more like this
house id 2 remove filter
legislature
25277
pref label House of Lords more like this
question text To ask His Majesty's Government what assessment they have made of the impact of the shortage of the psychotropic medication Olanzapine, and what steps they are taking to ensure that such shortages do not affect the health and safety of patients, and wider public safety. more like this
tabling member printed
Lord Carlile of Berriew more like this
uin HL3730 more like this
answer
answer
is ministerial correction false more like this
date of answer less than 2024-04-22more like thismore than 2024-04-22
answer text <p>We are aware that there have been supply constraints with olanzapine 210 milligram, 300 milligram, and 405 milligram powder and solvent for prolonged release suspension for injection. We worked with manufacturers to uplift production, and the issues were resolved in February 2024. We worked with NHS England to issue national communications containing advice on how to manage patients whilst there was a disruption to supply. We are not aware of any supply issues affecting oral presentations of olanzapine, or of any supply issues with any risperidone or haloperidol products.</p> more like this
answering member printed Lord Markham more like this
grouped question UIN HL3729 more like this
question first answered
less than 2024-04-22T15:15:21.743Zmore like thismore than 2024-04-22T15:15:21.743Z
answering member
4948
label Biography information for Lord Markham more like this
tabling member
1138
label Biography information for Lord Carlile of Berriew more like this
1700674
registered interest false more like this
date less than 2024-04-15more like thismore than 2024-04-15
answering body
Department of Health and Social Care more like this
answering dept id 17 more like this
answering dept short name Health and Social Care more like this
answering dept sort name Health and Social Care more like this
hansard heading Tofersen: Licensing more like this
house id 2 remove filter
legislature
25277
pref label House of Lords more like this
question text To ask His Majesty's Government what assessment they have made of the negative impact on pharmaceutical research investment in the UK of the refusal by National Institute for Health and Care Excellence to approve tofersen for SOD-1 MND patients in the UK. more like this
tabling member printed
Baroness Finlay of Llandaff more like this
uin HL3732 more like this
answer
answer
is ministerial correction false more like this
date of answer less than 2024-04-22more like thismore than 2024-04-22
answer text <p>The National Institute for Health and Care Excellence (NICE) has not yet started its evaluation of tofersen for treating amyotrophic lateral sclerosis caused by SOD1 gene mutations, and has therefore not published any guidance or recommendations on whether tofersen should be available for National Health Service patients. In developing its recommendations, the NICE will follow its published methods for health technology evaluation, which will include a thorough assessment of the available evidence. This takes into account all health-related costs and benefits, including health benefits not only to patients but, where relevant, to other people such as carers. The NICE’s aim is to publish its guidance on tofersen as close as possible to the date it receives its marketing authorisation.</p> more like this
answering member printed Lord Markham more like this
grouped question UIN HL3733 more like this
question first answered
less than 2024-04-22T15:05:49.787Zmore like thismore than 2024-04-22T15:05:49.787Z
answering member
4948
label Biography information for Lord Markham more like this
tabling member
3609
label Biography information for Baroness Finlay of Llandaff more like this
1700675
registered interest false more like this
date less than 2024-04-15more like thismore than 2024-04-15
answering body
Department of Health and Social Care more like this
answering dept id 17 more like this
answering dept short name Health and Social Care more like this
answering dept sort name Health and Social Care more like this
hansard heading Tofersen more like this
house id 2 remove filter
legislature
25277
pref label House of Lords more like this
question text To ask His Majesty's Government what consideration was given to the costs of complicated grief in families of patients dying from SOD-1 MND during the evaluation process that led to the decision to decline access to tofersen for NHS patients. more like this
tabling member printed
Baroness Finlay of Llandaff more like this
uin HL3733 more like this
answer
answer
is ministerial correction false more like this
date of answer less than 2024-04-22more like thismore than 2024-04-22
answer text <p>The National Institute for Health and Care Excellence (NICE) has not yet started its evaluation of tofersen for treating amyotrophic lateral sclerosis caused by SOD1 gene mutations, and has therefore not published any guidance or recommendations on whether tofersen should be available for National Health Service patients. In developing its recommendations, the NICE will follow its published methods for health technology evaluation, which will include a thorough assessment of the available evidence. This takes into account all health-related costs and benefits, including health benefits not only to patients but, where relevant, to other people such as carers. The NICE’s aim is to publish its guidance on tofersen as close as possible to the date it receives its marketing authorisation.</p> more like this
answering member printed Lord Markham more like this
grouped question UIN HL3732 more like this
question first answered
less than 2024-04-22T15:05:49.847Zmore like thismore than 2024-04-22T15:05:49.847Z
answering member
4948
label Biography information for Lord Markham more like this
tabling member
3609
label Biography information for Baroness Finlay of Llandaff more like this
1700683
registered interest false more like this
date less than 2024-04-15more like thismore than 2024-04-15
answering body
Department of Health and Social Care more like this
answering dept id 17 more like this
answering dept short name Health and Social Care more like this
answering dept sort name Health and Social Care more like this
hansard heading NHS: Staff more like this
house id 2 remove filter
legislature
25277
pref label House of Lords more like this
question text To ask His Majesty's Government what is their assessment of the impact of the NHS long-term workforce plan upon the number of specialists such as Parkinson’s nurses in the NHS. more like this
tabling member printed
Baroness Gale more like this
uin HL3741 more like this
answer
answer
is ministerial correction false more like this
date of answer less than 2024-04-22more like thismore than 2024-04-22
answer text <p>In June 2023, we published the Long Term Workforce Plan which sets out the steps the National Health Service and its partners need to take to deliver an NHS workforce that meets the changing needs of the population over the next 15 years.</p><p>The Plan commits to double the number of medical places, taking the total number of places to 15,000 by 2031/32 and including a commensurate increase in specialty training places that meets the demands of the NHS in the future. It also commits to increasing adult nursing places by 92%, taking the number of total places up to nearly 38,000 by 2031/32.</p><p>There are a record number of nurses working in the NHS and we have reached our target of 50,000 additional nurses, meaning we have delivered on our commitment six months early. In January 2024 there are over 363,000 nurses working across the NHS, representing over 62,000 more than in September 2019.</p> more like this
answering member printed Lord Markham more like this
question first answered
less than 2024-04-22T15:39:17.07Zmore like thismore than 2024-04-22T15:39:17.07Z
answering member
4948
label Biography information for Lord Markham more like this
tabling member
2503
label Biography information for Baroness Gale more like this
1700749
registered interest false more like this
date less than 2024-04-15more like thismore than 2024-04-15
answering body
Department for Work and Pensions more like this
answering dept id 29 more like this
answering dept short name Work and Pensions more like this
answering dept sort name Work and Pensions more like this
hansard heading State Retirement Pensions: Women more like this
house id 2 remove filter
legislature
25277
pref label House of Lords more like this
question text To ask His Majesty's Government when they will respond to the report from the Parliamentary and Health Service Ombudsman Women’s State Pension age: our findings on injustice and associated issues laid before Parliament on 21 March. more like this
tabling member printed
Baroness Ritchie of Downpatrick more like this
uin HL3789 more like this
answer
answer
is ministerial correction false more like this
date of answer less than 2024-04-22more like thismore than 2024-04-22
answer text <p>In laying the report before Parliament at the end of March, the Ombudsman has brought matters to the attention of this House, and a further update to the House will be provided once the report's findings have been fully considered.</p> more like this
answering member printed Viscount Younger of Leckie more like this
question first answered
less than 2024-04-22T14:05:38.503Zmore like thismore than 2024-04-22T14:05:38.503Z
answering member
4169
label Biography information for Viscount Younger of Leckie more like this
tabling member
4130
label Biography information for Baroness Ritchie of Downpatrick more like this